| Accession |
PRJCA030197 |
| Title |
Data on genetic results and statistical analysis data from Phase I clinical trials of Clifutinib Besylate for the treatment of AML. AML Phase I clinical trial |
| Relevance |
Medical |
| Data types |
Genome sequencing
|
| Organisms |
Homo sapiens
|
| Description |
To explore the correlation analysis between the baseline mutation characteristics of R/R AML and the efficacy of clifutinib monotherapy. In addition, the relationship between gene mutation and efficacy during treatment was monitored and the possible mechanism of drug resistance was explored. |
| Sample scope |
Multiisolate |
| Release date |
2024-10-01 |
| Grants |
| Agency |
program |
Grant ID |
Grant title |
| HEC Pharm GmbH
|
|
2017L00790/2017L00791/2017L00792
|
|
|
|
| Submitter |
zhijie
wang (wangzhijie@hec.cn)
|
| Organization |
Guangdong Dongyangguang Pharmaceutical Co., Ltd |
| Submission date |
2024-09-14 |
